Giving Bayer's oral Factor XIa inhibitor asundexian to people who have suffered an ischaemic stroke can reduce the risk of them having another by around a quarter. That is the conclusion of the ...

Sean Williams is a data-driven Motley Fool contributing analyst who's been investing for 27 years and has penned north of 15,000 articles. You'll find him at the intersection of politics and investing ...